13 hours ago · A prescriber may obtain a patient activity report, a list of patients for whom the prescriber wrote a controlled substance prescription, and an audit report on the prescriber’s delegates’ use of CURES. Information about a patient’s out-of-state prescriptions may be requested as part of a patient activity report. A patient activity report ... >> Go To The Portal
Data contained in CURES is reported to the DOJ by pharmacies and direct dispensers. If you are a patient or prescriber with incorrect information on your CURES report, please notify the reporting pharmacy of the error. Only the original reporting pharmacy or dispenser may submit prescription corrections to the DOJ.
CURES contains the following information: patient name, patient date of birth, patient address, prescriber name, prescriber DEA number, pharmacy name, pharmacy license number, date prescription was filled, prescription number, drug name, form, quantity and strength, refill number, and number of days supply.
Access to CURES is strictly limited. Licensed health care practitioners and licensed pharmacists may access information in CURES only for patients under their care.
An individual can obtain his or her CURES prescription history report through the Information Practices Act (IPA).
The required notification may be accomplished electronically by logging into the prescriber's CURES account, or by emailing SecurityPrinter@doj.ca.gov to obtain a report to file with the California DOJ. Prescribers should also notify the California State Board of Pharmacy at BOPcomplaint@dca.ca.gov.
Who has access to CURES information? As outlined in Health & Safety Code section 11165.1(a)(1)(A), prescribers authorized to prescribe, order, administer, furnish, or dispense Schedule II, III, or IV controlled substances, and pharmacists, may access CURES data for patient care purposes.
California licensed pharmacists must register for access to CURES 2.0 by July 1, 2016, or upon issuance of a Board of Pharmacy Pharmacist License, whichever occurs later.
While a physician can have a registered delegate request the CURES report, the report will go into the physician's dashboard on CURES so the physician can review the PAR prior to prescribing, ordering, administering, or furnishing. 4.
Patient Search – Prescribers & Dispensers For Prescriber, Dispenser, and Delegate users, CURES records can be searched up to 12 months using the date range option.
by Drugs.com The anti-seizure medication gabapentin is not currently considered a narcotic or controlled substance by the federal government, but certain states have enacted legislation so that the medication is treated as one or monitored by the state's prescription drug monitoring program.
The law now requires physicians and pharmacists to check the database before prescribing or filling the drugs. Dr. Andy Anderson is the chief medical officer at Aurora Health Care. He also serves on the state's opioid task force.
C.U.R.E.S. Mandated The C.U.R.E.S. 2.0 medication database was certified as ready for statewide use on April 2, 2018. Six months later, starting October 2, 2018, all California physicians and other prescribing health care professionals were mandated by California Medical Board rules to consult C.U.R.E.S. C.U.R.E.S.
The Drug Enforcement Administration (DEA), the Centers for Disease Control and Prevention (CDC) and the Ultram® package insert indicate that tramadol is a controlled substance which contains an opioid.